1. Home
  2. XBIT vs JRVR Comparison

XBIT vs JRVR Comparison

Compare XBIT & JRVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XBIT
  • JRVR
  • Stock Information
  • Founded
  • XBIT 2005
  • JRVR 2002
  • Country
  • XBIT United States
  • JRVR Bermuda
  • Employees
  • XBIT N/A
  • JRVR N/A
  • Industry
  • XBIT Pharmaceuticals and Biotechnology
  • JRVR Property-Casualty Insurers
  • Sector
  • XBIT Health Care
  • JRVR Finance
  • Exchange
  • XBIT Nasdaq
  • JRVR Nasdaq
  • Market Cap
  • XBIT 242.2M
  • JRVR 241.0M
  • IPO Year
  • XBIT 2015
  • JRVR 2005
  • Fundamental
  • Price
  • XBIT $7.45
  • JRVR $6.45
  • Analyst Decision
  • XBIT
  • JRVR Buy
  • Analyst Count
  • XBIT 0
  • JRVR 6
  • Target Price
  • XBIT N/A
  • JRVR $11.17
  • AVG Volume (30 Days)
  • XBIT 50.6K
  • JRVR 251.1K
  • Earning Date
  • XBIT 11-07-2024
  • JRVR 11-05-2024
  • Dividend Yield
  • XBIT N/A
  • JRVR 3.10%
  • EPS Growth
  • XBIT N/A
  • JRVR N/A
  • EPS
  • XBIT N/A
  • JRVR N/A
  • Revenue
  • XBIT N/A
  • JRVR $815,639,000.00
  • Revenue This Year
  • XBIT N/A
  • JRVR N/A
  • Revenue Next Year
  • XBIT N/A
  • JRVR $8.37
  • P/E Ratio
  • XBIT N/A
  • JRVR $3.41
  • Revenue Growth
  • XBIT N/A
  • JRVR 23.89
  • 52 Week Low
  • XBIT $3.51
  • JRVR $6.12
  • 52 Week High
  • XBIT $9.96
  • JRVR $15.47
  • Technical
  • Relative Strength Index (RSI)
  • XBIT 55.47
  • JRVR 47.99
  • Support Level
  • XBIT $7.05
  • JRVR $6.14
  • Resistance Level
  • XBIT $7.60
  • JRVR $6.64
  • Average True Range (ATR)
  • XBIT 0.47
  • JRVR 0.21
  • MACD
  • XBIT -0.02
  • JRVR 0.04
  • Stochastic Oscillator
  • XBIT 71.43
  • JRVR 63.46

About XBIT XBiotech Inc.

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.

About JRVR James River Group Holdings Ltd.

James River Group Holdings Ltd owns and operates a group of specialty insurance and reinsurance companies. It reports business into three segments. The Excess and Surplus Lines segment, which is the key revenue driver, offers commercial excess and surplus lines liability and excess property insurance products; The Specialty Admitted Insurance segment focuses on niche classes within the standard insurance markets with a primary focus on fronting business, where it retains a minority share of the risk and seek to earn fee income by allowing other carriers and producers to use its licensure, ratings, expertise and infrastructure. and the Corporate and other segment consists of the management and treasury activities of holding companies, equity compensation for the group.

Share on Social Networks: